GUYER WILLIAM (Chief Development Officer) sold 90.0% of their position (20K shares) of CORCEPT THERAPEUTICS INC on the open market
Open‑market sale worth $1.04M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/7/2026ACC: 0001193125-26-212118
Officer· Chief Development Officer
Since Aug 2021
-20K
Net shares
Net seller
$1.04M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
20K acquired · 40K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+20K
Price / share
$21.65
Trade value
$433K
% of position
896.5%
5/5/2026
2.23K→22.23K
Common Stock
Direct
Shares
−20K
Price / share
$51.83
Trade value
$1.04M
% of position
90.0%
5/5/2026
22.23K→2.23K
Total
Net shares
+0.00
Net value
-$603.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/5/2026 | M · Option Exercise | +20K | $21.65 | $433K | 896.5% | 2.23K | 22.23K |
| Common Stock Direct | 5/5/2026 | S · Sale | −20K | $51.83 | $1.04M | 90.0% | 22.23K | 2.23K |
| Total | +0.00 | -$603.60K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
20K shares
Shares
−20K
Strike price
21.65
Held after
170K
Exercisable
—
5/5/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock20K shares | 5/5/2026 | M · Option Exercise | −20K | 21.65 | — | 170K |